Trial NCT01601626

View at ClinicalTrials.gov 
Org. Study IDs: ACTG A5290
Secondary IDs: 1U01AI068636

Last trial update was posted on 2018-02-13

MeSH Interventions

Ethambutol Isoniazid Lopinavir Pyrazinamide Pyridoxine Raltegravir Potassium Rifabutin Rifampin Ritonavir Vitamin B 6

MeSH Conditions

Tuberculosis

Other Conditions

HIV Infection

Stopping Reasons

The study was stopped early due to feasibility concerns.

Limitations And Caveats

The study was terminated after 71 of 471 participants enrolled. Therefore, the study was under-powered and formal statistical comparisons between study arms were not undertaken as originally planned. Instead, summaries within study arm were provided.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID